221 related articles for article (PubMed ID: 32127550)
21. Comparing the effect of sucrose gel and metronidazole gel in treatment of clinical symptoms of bacterial vaginosis: a randomized controlled trial.
Khazaeian S; Navidian A; Navabi-Rigi SD; Araban M; Mojab F; Khazaeian S
Trials; 2018 Oct; 19(1):585. PubMed ID: 30367673
[TBL] [Abstract][Full Text] [Related]
22. Orally administrated
Qi F; Fan S; Fang C; Ge L; Lyu J; Huang Z; Zhao S; Zou Y; Huang L; Liu X; Liang Y; Zhang Y; Zhong Y; Zhang H; Xiao L; Zhang X
Front Immunol; 2023; 14():1125239. PubMed ID: 37575226
[TBL] [Abstract][Full Text] [Related]
23. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
[TBL] [Abstract][Full Text] [Related]
24. Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: impact on fastidious bacteria.
Mitchell CM; Hitti JE; Agnew KJ; Fredricks DN
BMC Infect Dis; 2009 Jun; 9():89. PubMed ID: 19515236
[TBL] [Abstract][Full Text] [Related]
25. [Probiotic monotherapy of bacterial vaginosis: a open, randomized trial].
Kovachev S; Dobrevski-Vacheva R
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():36-42. PubMed ID: 24294744
[TBL] [Abstract][Full Text] [Related]
26. Bacterial vaginosis: a review on clinical trials with probiotics.
Mastromarino P; Vitali B; Mosca L
New Microbiol; 2013 Jul; 36(3):229-38. PubMed ID: 23912864
[TBL] [Abstract][Full Text] [Related]
27. Deep sequencing of the vaginal microbiota of women with HIV.
Hummelen R; Fernandes AD; Macklaim JM; Dickson RJ; Changalucha J; Gloor GB; Reid G
PLoS One; 2010 Aug; 5(8):e12078. PubMed ID: 20711427
[TBL] [Abstract][Full Text] [Related]
28. Treatment considerations for bacterial vaginosis and the risk of recurrence.
Chen JY; Tian H; Beigi RH
J Womens Health (Larchmt); 2009 Dec; 18(12):1997-2004. PubMed ID: 20044862
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence.
Bohbot JM; Daraï E; Bretelle F; Brami G; Daniel C; Cardot JM
J Gynecol Obstet Hum Reprod; 2018 Feb; 47(2):81-86. PubMed ID: 29196153
[TBL] [Abstract][Full Text] [Related]
30. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
[TBL] [Abstract][Full Text] [Related]
31. Probiotics in addition to metronidazole for treatment Trichomonas vaginalis in the presence of BV: a randomized, placebo-controlled, double-blind study.
Sgibnev A; Kremleva E
Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):345-351. PubMed ID: 31705339
[TBL] [Abstract][Full Text] [Related]
32. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV.
Hummelen R; Changalucha J; Butamanya NL; Cook A; Habbema JD; Reid G
Int J Gynaecol Obstet; 2010 Dec; 111(3):245-8. PubMed ID: 20801446
[TBL] [Abstract][Full Text] [Related]
33. The effect of prebiotic vaginal gel with adjuvant oral metronidazole tablets on treatment and recurrence of bacterial vaginosis: a triple-blind randomized controlled study.
Hakimi S; Farhan F; Farshbaf-Khalili A; Dehghan P; Javadzadeh Y; Abbasalizadeh S; Khalvati B
Arch Gynecol Obstet; 2018 Jan; 297(1):109-116. PubMed ID: 28983665
[TBL] [Abstract][Full Text] [Related]
34. Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use.
Bradshaw CS; Vodstrcil LA; Hocking JS; Law M; Pirotta M; Garland SM; De Guingand D; Morton AN; Fairley CK
Clin Infect Dis; 2013 Mar; 56(6):777-86. PubMed ID: 23243173
[TBL] [Abstract][Full Text] [Related]
35. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs.
van de Wijgert J; Verwijs MC
BJOG; 2020 Jan; 127(2):287-299. PubMed ID: 31299136
[TBL] [Abstract][Full Text] [Related]
36. Molecular assessment of bacterial vaginosis by Lactobacillus abundance and species diversity.
Dols JA; Molenaar D; van der Helm JJ; Caspers MP; de Kat Angelino-Bart A; Schuren FH; Speksnijder AG; Westerhoff HV; Richardus JH; Boon ME; Reid G; de Vries HJ; Kort R
BMC Infect Dis; 2016 Apr; 16():180. PubMed ID: 27107961
[TBL] [Abstract][Full Text] [Related]
37. Changes in the vaginal microenvironment with metronidazole treatment for bacterial vaginosis in early pregnancy.
Mitchell C; Balkus J; Agnew K; Lawler R; Hitti J
J Womens Health (Larchmt); 2009 Nov; 18(11):1817-24. PubMed ID: 19951217
[TBL] [Abstract][Full Text] [Related]
38. Vaginal & gut microbiota diversity in pregnant women with bacterial vaginosis & effect of oral probiotics: An exploratory study.
Vasundhara D; Raju VN; Hemalatha R; Nagpal R; Kumar M
Indian J Med Res; 2021 Apr; 153(4):492-502. PubMed ID: 34380796
[TBL] [Abstract][Full Text] [Related]
39. Response to Antibiotic Treatment of Bacterial Vaginosis Predicts the Effectiveness of LACTIN-V (Lactobacillus crispatus CTV-05) in the Prevention of Recurrent Disease.
Hemmerling A; Wierzbicki MR; Armstrong E; Cohen CR
Sex Transm Dis; 2024 Jun; 51(6):437-440. PubMed ID: 38733973
[TBL] [Abstract][Full Text] [Related]
40. BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial.
Zeron Mullins M; Trouton KM
Trials; 2015 Jul; 16():315. PubMed ID: 26210791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
